B
Bonti
Biotech & Life Sciences · Newport Beach, United States · Founded 2015
Biotechnology company based in orange, california MoreLess
Bonti operates in the biopharmaceutical sector, focusing on developing innovative treatments for various medical conditions. The company primarily serves patients suffering from atopic dermatitis and pediatric spasticity, among other conditions. Bonti's business model revolves around extensive research and development (R&D) to create effective therapies, which are then brought to market following rigorous clinical trials and regulatory approvals. Revenue is generated through the sale of these approved treatments, as well as potential partnerships and licensing agreements with other pharmaceutical companies. The market Bonti operates in is highly regulated and competitive, requiring continuous innovation and adherence to strict legal standards. The company aims to improve patient outcomes through cutting-edge biopharmaceutical solutions.
Keywords: biopharmaceutical, atopic dermatitis, pediatric spasticity, clinical trials, regulatory approvals, R&D, innovative treatments, patient outcomes, licensing agreements, pharmaceutical partnerships.
Company overview
Bonti company information
The essential company record, classifications and operating signals in one place.
- Status
- Acquired
- Founded
- 2015
- Headquarters
- Newport Beach, United States
- Employees
- —
- Open positions
- None listed
- Dealroom signal
- 57.0
Valuation & funding
Bonti funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITION✓Exit | Sep 2018 | $195M | $195M | Allergan | — |
| SERIES C✓Equity / VC | Jan 2018 | $16M | $62M | City Hill Ventures | — |
| SERIES B✓Equity / VC | Apr 2017 | $12M | $47M | City Hill Ventures · JMCR Partners · Viva Ventures Biotech Fund · Colt Ventures | — |
| SERIES A✓Equity / VC | Aug 2015 | $8.9M | $36M | Undisclosed | — |
Growth signals
Bonti website traffic
Latest recorded traffic for Bonti is 0 monthly website visits.
Comparisons
Bonti compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Bonti's talent
Source: Dealroom Talent Intelligence.
Investors
6 investors on Bonti's cap table
Sourced from Dealroom's funding and investor records.
Global footprint
Where Bonti has talent and traffic
In the news
Latest news about Bonti
Recent press, funding announcements, and product moves mentioning Bonti — open to read from the original sources.
Market sentiment
What the market is saying about Bonti
An AI-synthesized read of the highest-engagement posts about Bonti on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Bonti’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.